SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 49 filers reported holding SOLENO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 137 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 137 | -51.4% | 0.00% | – |
| Q4 2021 | $0 | – | 282 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 282 | -92.7% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 3,883 | -24.0% | 0.00% | – |
| Q1 2021 | $6,000 | -33.3% | 5,112 | +5.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 4,870 | +8443.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 57 | -89.3% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 535 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 535 | -5.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 568 | +3241.2% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | -19.0% | 0.00% | – |
| Q1 2019 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 21 | +2000.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,438,060 | $5,266,000 | 1.15% |
| Vivo Capital, LLC | 4,359,683 | $9,417,000 | 0.95% |
| Trellus Management Company, LLC | 152,829 | $330,000 | 0.48% |
| SABBY MANAGEMENT, LLC | 755,312 | $1,631,000 | 0.21% |
| 683 Capital Management, LLC | 844,112 | $1,823,000 | 0.12% |
| SHIKIAR ASSET MANAGEMENT INC | 30,300 | $65,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 21,587 | $47,000 | 0.01% |
| Kepos Capital LP | 37,591 | $81,000 | 0.00% |
| DEUTSCHE BANK AG\ | 86 | $0 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 11,851 | $26,000 | 0.00% |